Why the Morning-After Pill Is Like a Really Popular Blog Post

Another milestone in the FDA's increasingly creative effort to delay a decision about emergency contraception:

A two-month comment period on making the "morning-after pill" Plan B available without a prescription ended yesterday, with as many as 10,000 comments apparently submitted but no indication of when or how the Food and Drug Administration will proceed with the controversial application.

Now that we're putting drug safety decisions to a nationwide vote, when can we expect a yea or a nay? In precisely the time it takes an FDA regulator to read 10,000 comments. Or not.

The agency's next step "will depend on what we see in the comments," said FDA spokeswoman Julie Zawisza. "We'll read them all and decide how to proceed."

I make the case for putting Barr's Plan B over the counter here. Reason's Ron Bailey discusses the FDA's War on Promiscuity here.